ABSTRACT
Background Word-finding difficulty is prevalent but poorly understood in persons with relapsing-remitting multiple sclerosis (RRMS).
Objective Investigate our hypothesis that phonological processing ability is below expectations and related to word-finding difficulty in patients with RRMS.
Method Data were analyzed from patients with RRMS (n=50) on patient-reported word-finding difficulty (PW-WFD) and objective performance on WIAT-4 Phonemic Proficiency (PP; analysis of phonemes within words), Word-Reading (WR, proxy of premorbid literacy and verbal ability), and Sentence Repetition (SR; auditory processing of word-level information).
Results Performance (mean [95% CI]) was reliably lower than normative expectations for PP (− 0.41[-0.69, -0.13]) but not for WR (0.02[-0.21, 0.25]) or SR (0.08[-0.15, 0.31]. Within-subjects performance was worse on PP than both WR (t[49]=4.00, p<0.001, d=0.47) and SR (t[49]=3.76, p<0.001, d=0.54). Worse PR-WFD was specifically related to lower PP (F2,47=6.24, p=0.004, η2=0.21); worse PP performance at PR-WFD Often (n=13; -1.16[-1.49, -0.83]) than Sometimes (n=17; -0.14[-0.68, 0.41]) or Rarely (n=20; -0.16[-0.58, 0.27]. PR-WFD was unrelated to WR or SR (Ps>0.25).
Conclusion Phonological processing was below expectations and specifically linked to word-finding difficulty in RRMS. Findings are consistent with early disease-related cortical changes within the posterior superior temporal / supramarginal region. Results inform our developing model of MS-related word-finding difficulty.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the Icahn School of Medicine at Mount Sinai gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
